Cannacord Genuity Cuts PT on Cree (CREE) to $41; Vertical Integration May be Wrong Strategy
Tweet Send to a Friend
Cannacord Genuity cuts its price target on Cree (Nasdaq: CREE) from $64 to $41 and maintains a Buy rating on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE